Status:
COMPLETED
Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4
Lead Sponsor:
University Hospital, Limoges
Conditions:
Colon Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In patients with colonic adenocarcinoma stage 4 which are potentially resectable metastases (lung and liver metastases), treatment with chemotherapy is necessary but not end in success in 10% of cases...
Detailed Description
A fragment of colon tumors will be taken from a specimen or a cold biopsy, tissue from patients diagnosed with colon carcinoma metastatic (stage 4). In parallel and systematically: analysis by the pat...
Eligibility Criteria
Inclusion
- patient with adenocarcinoma of the colon diagnosed at stage 4 receiving standard therapy
- targets must be measurable tumor lesions (RECIST)
- patient has not expressed opposition to the use of their residual tumor
Exclusion
- Against-formal indication to an indispensable para-clinical examination of the patient monitoring
- Use of chemotherapy, hormone therapy or concomitant radiotherapy
- Cons-indication for chemotherapy
- Are pregnant, nursing or lack of contraception for women of childbearing age.
Key Trial Info
Start Date :
March 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02305368
Start Date
March 1 2011
End Date
March 1 2013
Last Update
December 2 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.